Mass Spectrometric Characterization of the MCF7 Cancer Cell Line: Proteome Profile and Cancer Biomarkers
The discovery of cancer biomarkers is crucial in the clinical setting to facilitate early diagnosis and treatment, thereby increasing survival rates. Proteomic technologies with mass spectrometry detection (MS) have the potential to affect the entire spectrum of cancer research by identifying these...
Main Author: | Sarvaiya, Hetal Abhijeet |
---|---|
Other Authors: | Biomedical Engineering and Sciences |
Format: | Others |
Published: |
Virginia Tech
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/10919/42169 http://scholar.lib.vt.edu/theses/available/etd-04212006-161144/ |
Similar Items
-
Insulin stimulated MCF7 breast cancer cells: Proteome dataset
by: Hetal A. Sarvaiya, et al.
Published: (2016-12-01) -
Mapping of proteomic lysate of a MCF-7 cancer cell line for the identification of potential markers for breast cancer
by: V. E. Shevchenko, et al.
Published: (2014-07-01) -
Global Metabolomics Reveals Urinary Biomarkers of Breast Cancer in a MCF-7 Xenograft Mouse Model
by: Frank J. Gonzalez, et al.
Published: (2013-08-01) -
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
by: Ming Lu, et al.
Published: (2007-01-01) -
LC-MS/MS Proteomic Study of MCF-7 Cell Treated with Dox and Dox-Loaded Calcium Carbonate Nanoparticles Revealed Changes in Proteins Related to Glycolysis, Actin Signalling, and Energy Metabolism
by: Hamidu Ahmed, et al.
Published: (2021-09-01)